Skip to content
Learn more about the benefits on becoming a member.
Member Companies: Submit a News Item
Home » Legislative Action » 10ab2352
Author: John A. Pérez (D - Los Angeles)CHI Position: SUPPORTSummary: Provides Medi-Cal coverage for anti-rejection medication for up to two years following an organ transplant. Also creates an eligibility class within Medi-Cal for transplant patients.
Current Bill Text, Status, and Location
CHI Letter of Support for AB 2352